Advanced search
Publication Cover
Current Medical Research and Opinion Volume 24, 2008 - Issue 7
Submit an article Journal homepage
329
Views
21
CrossRef citations to date
0
Altmetric
Original Article

Burden of illness of bilateral neovascular age-related macular degeneration in Spain*

José María Ruiz-Moreno University of Castilla La Mancha, Albacete, Spain
,
Rosa María Coco Instituto de Oftalmobiología Aplicada (IOBA), Universidad de Valladolid, Valladolid, Spain
,
José García-Arumí Hospital Vall d’Hebrón, Barcelona, SpainCorrespondence[email protected]
,
Xiao Xu Covance Market Access Services Inc, Gaithersburg, Maryland, USA
&
Gergana Zlateva Pfizer Inc, New York, NY, USA
Pages 2103-2111 | Accepted 20 May 2008, Published online: 10 Jun 2006

References

  • Ambati J, Ambati BK, Yoo SH, . Age-related macular degeneration: etiology, pathogenesis and therapeutic strategies. Surv Ophthalmol 2003; 48:257–93
  • Bird AC, Bressler NM, Bressler SB, . An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995; 39:367–74
  • Maguire MG. Age-Related Macular Degeneration. Natural historyBerger JW, Fine SL, Maguire MG. St. Louis, Mo: Mosby, 1999;17–30
  • Gottlieb JL. Age-related macular degeneration. JAMA 2002; 288:2233–6
  • Seddon JM. Epidemiology of age-related macular degeneration. Retina. 3rd ednSchachat AP, Ryan SJ. St. Louis, Mo: Mosby, 2001;1039–50
  • Ferris III FL, Fine SL, Hyman LA. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol 1984; 102:1640–2
  • Augood CA, Vingerling JR, de Jong PT, . Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). Arch Ophthalmol 2006; 124:529–35
  • Williams RA, Brody BL, Thomas RG, . The psychosocial impact of macular degeneration. Arch Ophthalmol 1998; 116:514–20
  • Ivers RQ, Cumming RG, Mitchell P, . Visual impairment and falls in older adults: the Blue Mountains Eye Study. J Am Geriatr Soc 1998; 46:58–64
  • Brody BL, Gamst AC, Williams RA, . Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology 2001; 108:1893–900
  • Soubrane G, Cruess A, Lotery A, . Burden and resource utilization of neovascular AMD: findings of a multicountry study. Arch Ophthalmol 2007; 125:1249–54
  • Mangione CM, Lee PP, Gutierrez PR, . Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 2001; 119:1050–8
  • Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001; 33:337–43
  • Dolan P. Modeling valuations for EuroQol health states. Med Care 1997; 35:1095–108
  • The EuroQol Group. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy 1990; 16:199–208
  • Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67:361–70
  • Herrero MJ, Blanch J, Peri JM, . A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. Gen Hosp Psychiatry 2003; 25:277–83
  • SOIKOS. Base de datos de costes sanitarios. Version 2.2Barcelona: SOIKOS, 2005
  • Clemons TE, Chew EY, Bressler SB, . National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 10. Arch Ophthalmol 2003; 121:211–17
  • Lindblad AS, Clemons TE. Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report no. 14. Arch Ophthalmol 2005; 123:1207–14
  • Miskala PH, Bressler NM, Meinert CL. Relative contributions of reduced vision and general health to NEI-VFQ scores in patients with neovascular age-related macular degeneration. Arch Ophthalmol 2004; 122:758–66
  • Park W. Vision rehabilitation for age-related macular degeneration. Int Ophthalmol Clin 1999; 39:143–62
  • Espallargues M, Czoski-Murray CJ, Bansback NJ, . The impact of age-related macular degeneration on health status utility values. Invest Ophthalmol Vis Sci. 2005; 46:4016–23
  • Bonastre J, Le Pen C, Anderson P, . The epidemiology, economics and quality of life burden of age-related macular degeneration in France, Germany, Italy and the United Kingdom. Eur J Health Econ 2002; 3:94–102
  • Bonastre J, Le Pen C, Soubrane G, . The burden of age-related macular degeneration: results of a cohort study in two French referral centers. Pharmacoeconomics 2003; 21:181–90

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.